ArticleDisease models & mechanisms2025
Evidence of neuronal DNA damage in the brains of patients with Rett syndrome.
Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Paediatric Genetic Diseases: Models, Mechanisms and Therapies.Disease models & mechanisms · 2026Article
- Disruption of DNA Repair as an Emerging Epigenetic Mechanism Underlying Autism Spectrum Disorder.Current psychiatry reports · 2026Review
- New insights into Rett syndrome pathogenesis: defining the role of MEPC2 in DNA damage.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Rett syndrome is characterized by the postnatal loss of neurophysiological function and regression of childhood development. Because the syndrome is X linked, and males with MECP2 mutations generally do not survive birth, the study of this syndrome has been complicated by the fact that, in the female brain, a portion of neurons express wild-type MECP2, and another portion of neurons express a non-functional allele of MECP2. Here, we present an approach that enables transcriptional profiling of individual neurons and direct comparison of neurons that express functional MECP2 with those that have diminished MECP2 function. With this novel profiling approach, we found that mutant neurons from the brains of patients with Rett syndrome show patterns of defects in expression of synaptic and metabolic genes. A similar analysis of rat brain lacking MECP2 expression yielded similar patterns, suggesting that rat is a suitable in vivo model of Rett syndrome. These analyses also identified DNA damage and senescence transcriptional signatures specifically in MECP2-null neurons, suggesting a possible trigger of dysfunction in Rett syndrome. Together, these data highlight potentially defective molecular, physiological and metabolic pathways in brain neurons of patients with Rett syndrome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.